Cytiva acquires Vanrx Pharmasystems

By The Science Advisory Board staff writers

February 1, 2021 -- Cytiva has acquired Vanrx Pharmasystems, a Canadian-based company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges.

This is the first acquisition by Cytiva since it became a Danaher operating company in April 2020, according to the company. The Vanrx portfolio complements Cytiva's manufacturing capacity solutions, focused on the last critical step before distribution to patients. With a shift toward smaller batches and personalized therapies, companies will need to bring complete bioprocessing workflows in-house, including aseptic filling solutions.

The SA25 Front Operator.
The SA25 Front Operator. Image courtesy of Cytiva.

Vanrx's flagship products -- SA25 Aseptic Filling Workcell and Microcell Vial Filler -- automate aseptic filling using robotics within closed, gloveless isolators. These solutions provide a fast path to a standardized filling capacity as the final step in manufacturing clinical and commercial biopharmaceutics.

"Cytiva becomes the first 'idea to injection' biotechnology company by bringing Vanrx into our already strong portfolio," said Olivier Loeillot, vice president and head of bioprocess at Cytiva. "From drug development, through drug substance and now into drug product, we can help biomanufacturers bring their therapies to patients faster. Vanrx will enhance Cytiva FlexFactory platforms and KUBio modular facilities, enabling us to accelerate biomanufacturing from start to finish."

Cytiva helps Clover scale up biomanufacturing of COVID-19 vaccine
Clover Biopharmaceuticals is working with Cytiva to scale up the company's COVID-19 vaccine manufacturing capabilities.
Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp...
GE BioPharma sale to Danaher is complete
The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter